US EditionPublished • loading... • Updated
China commerce minister meets pharma executives amid push for foreign investment
China plans stronger intellectual property protection and greater policy transparency to attract foreign pharmaceutical investment, with foreign direct investment down 5.7% in January, officials said.
- On March 22, 2026, Wang Wentao, Chinese Commerce Minister, met with Stephen Ubl and executives from five multinational drugmakers at the China Development Forum in Beijing.
- Facing falling FDI, China saw foreign direct investment fall to just over 92 billion yuan in January and added 200 sectors in December for investment incentives.
- Wang held talks with PhRMA's Stephen Ubl and industry leaders on foreign-invested pharmaceutical enterprises and noted the 15th Five-Year Plan lists biopharmaceuticals as a pillar industry.
- The minister said China will strengthen intellectual property protection and improve policy transparency, while Chinese Premier Li Qiang pledged on March 22, 2026, to further open the economy and fully implement national treatment for foreign enterprises.
- The forum, which ends on March 23, 2026, takes place amid rising tensions and a record $1.2 trillion trade surplus for 2025, as Beijing seeks foreign investment.
Insights by Ground AI
7 Articles
7 Articles
Chinese Vice Premier He Lifeng met with the heads of more than 10 well-known multinational companies, including HSBC and UBS, in Beijing yesterday and said that China will unswervingly expand its opening up, welcome multinational companies to increase their investment in China, and continuously deepen mutually beneficial cooperation.
Coverage Details
Total News Sources7
Leaning Left2Leaning Right1Center3Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 33%
C 50%
R 17%
Factuality
To view factuality data please Upgrade to Premium
